| Perpetual Credit Income Trust (PCI) ORDINARY UNITS FULLY PAID |
Financials |
$804 |
Deputy Portfolio Manager role update
|
3 Feb 2026 9:06AM |
$1.110 |
$1.100 |
fallen by
0.90%
|
|
| TerraCom Limited (TER) ORDINARY FULLY PAID |
Energy |
$121 |
Change of Director's Interest Notice (M Lochtenberg)
|
3 Feb 2026 9:06AM |
$0.065 |
$0.067 |
risen by
3.08%
|
|
| TerraCom Limited (TER) ORDINARY FULLY PAID |
Energy |
$121 |
Change of Director's Interest Notice (G Lewis)
|
3 Feb 2026 9:05AM |
$0.065 |
$0.067 |
risen by
3.08%
|
|
| Morphic Ethical Equities Fund Limited (MEC) ORDINARY FULLY PAID |
Financials |
$37 |
Update - Notification of buy-back - MEC
|
3 Feb 2026 9:05AM |
$1.155 |
$1.195 |
risen by
3.46%
|
|
| TerraCom Limited (TER) ORDINARY FULLY PAID |
Energy |
$121 |
Change of Director's Interest Notice (D McCarthy)
|
3 Feb 2026 9:05AM |
$0.065 |
$0.067 |
risen by
3.08%
|
|
| Sunrise Energy Metals Limited (SRL) ORDINARY FULLY PAID |
Materials |
$1,146 |
Change in substantial holding
|
3 Feb 2026 9:04AM |
$10.420 |
$7.980 |
fallen by
23.42%
|
|
| Algorae Pharmaceuticals Limited (1AI) ORDINARY FULLY PAID |
Health Care |
$29 |
1AI Corporate Presentation
|
3 Feb 2026 9:04AM |
$0.020 |
$0.017 |
fallen by
15%
|
|
| Commonwealth Bank of Australia (CBA) ORDINARY FULLY PAID |
Financials |
$296,655 |
Items impacting CBA's financial reporting
|
3 Feb 2026 9:03AM |
$151.480 |
$177.270 |
risen by
17.03%
|
|
| Unico Silver Limited (USL) ORDINARY FULLY PAID |
Materials |
$561 |
Application for quotation of securities - USL
|
3 Feb 2026 9:03AM |
$0.810 |
$0.890 |
risen by
9.88%
|
|
| Great Divide Mining Ltd (GDM) ORDINARY FULLY PAID |
Materials |
$28 |
Trading Halt
|
3 Feb 2026 9:02AM |
$0.420 |
$0.405 |
fallen by
3.57%
|
|
GDM - Price-sensitive ASX Announcement
Full Release
Key Points
- Trading halt requested by Great Divide Mining Ltd.
- Halt related to potential capital raising.
- Securities to remain halted until 5 February 2026 or an announcement.
- Request authorized by the Board of Directors.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Nimy Resources Limited (NIM) ORDINARY FULLY PAID |
Materials |
$22 |
Significant Gallium Extensions identified at Block 3
|
3 Feb 2026 9:02AM |
$0.057 |
$0.061 |
risen by
7.02%
|
|
NIM - Price-sensitive ASX Announcement
Full Release
Key Points
- High-resolution magnetic survey indicates the gallium resource at Block 3 extends another 3.5km.
- Current JORC Resource of 2,700t of gallium trioxide is open for expansion.
- Potential for significant inventory increase along a 400m corridor.
- Nimy in discussions to access $1.2B Federal Government critical minerals fund.
- Strategic Metallurgy appointed for high-grade gallium concentrate test work.
- Exploration targets defined to a total of 26Mt at 100g/t Ga2O3 and 100Mt at 810ppm TREO.
- Nimy collaborating with M2i Global for U.S. market supply chain.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Barton Gold Holdings Limited (BGD) ORDINARY FULLY PAID |
Materials |
$273 |
2026 Tunkillia Development Drilling Programs Begin
|
3 Feb 2026 9:00AM |
$1.130 |
$1.145 |
risen by
1.33%
|
|
BGD - Price-sensitive ASX Announcement
Full Release
Key Points
- Barton Gold Holdings Limited commences the 2026 Tunkillia development drilling program.
- The program includes 28,000m of reverse circulation drilling and 3,000m of diamond drilling.
- Aims to convert remaining open pit mineralisation to JORC (2012) Indicated category.
- Targeting a pre-feasibility study and Mining Lease application by the end of 2026.
- Current gold and silver prices are higher than past estimates, enhancing project economics.
- Objective to achieve a gold production target of 150,000 ounces annually.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sparc Technologies Limited (SPN) ORDINARY FULLY PAID |
Materials |
$23 |
Sparc Partner with AIML on AI Corrosion Assessment
|
3 Feb 2026 8:59AM |
$0.230 |
$0.195 |
fallen by
15.22%
|
|
SPN - Price-sensitive ASX Announcement
Full Release
Key Points
- Sparc Technologies partners with AIML for AI software development.
- The software aims to enhance protective coatings performance assessment.
- Utilizes advanced computer vision and machine learning techniques.
- Successful proof-of-concept under ISO 12944 corrosion boundary testing.
- Target market includes approximately 850 global labs.
- Software expected to replace outdated manual corrosion assessment methods.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Praemium Limited (PPS) ORDINARY FULLY PAID |
Information Technology |
$349 |
HY2026 Results Presentation
|
3 Feb 2026 8:58AM |
$0.755 |
$0.715 |
fallen by
5.30%
|
|
| Xpedra Resources Limited (XPD) ORDINARY FULLY PAID |
Materials |
$16 |
Appointment of Managing Director
|
3 Feb 2026 8:57AM |
$0.024 |
$0.027 |
risen by
12.50%
|
|
XPD - Price-sensitive ASX Announcement
Full Release
Key Points
- Scott Funston appointed as Managing Director of Xpedra Resources Limited.
- Xpedra to start maiden drilling program at Springfield Gold Deposit, NSW.
- Scott Funston has significant experience in the resources sector.
- His remuneration includes $250,000 plus superannuation and performance-based incentives.
- Performance Rights issuance subject to shareholder approval.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Imricor Medical Systems Inc (IMR) CDI 1:1 US PERSON PROHIBITED EXCLUDING QIB |
Health Care |
$661 |
Oklahoma Heart Institute to Become 4th US VISABL-AFL Site
|
3 Feb 2026 8:57AM |
$1.950 |
$2.060 |
risen by
5.64%
|
|
IMR - Price-sensitive ASX Announcement
Full Release
Key Points
- Oklahoma Heart Institute (OHI) has joined Imricor’s VISABL-AFL clinical trial.
- OHI is the fourth U.S. site in the VISABL-AFL trial, alongside University of Virginia, Virginia Commonwealth University, and Johns Hopkins University.
- OHI's participation aims to accelerate patient recruitment for the VISABL-AFL trial to support U.S. FDA approval.
- OHI has established cardiology-owned MRI facilities, reducing organizational barriers to adoption.
- Procedures at OHI are expected to start in March.
- Dr. Edward T. Martin is the Principal Investigator for VISABL-AFL at OHI.
- Dr. Martin is a Master of the Society for Cardiovascular Magnetic Resonance.
- Imricor’s CEO, Steve Wedan, highlights the sophisticated cardiology-led model of care at OHI.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Xpedra Resources Limited (XPD) ORDINARY FULLY PAID |
Materials |
$16 |
Investor Presentation
|
3 Feb 2026 8:56AM |
$0.024 |
$0.027 |
risen by
12.50%
|
|
| Naos Emerging Opportunities Company Limited (NCC) ORDINARY FULLY PAID |
Financials |
$31 |
Q2 FY26 Investor Update and Q&A - Presentation Materials
|
3 Feb 2026 8:55AM |
$0.440 |
$0.425 |
fallen by
3.41%
|
|
| Memphasys Limited (MEM) ORDINARY FULLY PAID |
Health Care |
$17 |
Regulatory Submissions Lodged for Felix
|
3 Feb 2026 8:55AM |
$0.007 |
$0.006 |
fallen by
14.29%
|
|
MEM - Price-sensitive ASX Announcement
Full Release
Key Points
- Memphasys lodged submission for Felixâ„¢ System on ARTG with expected TGA approval by April 2026.
- Submission lodged with CDSCO in India for regulatory approval, with review expected in six months.
- Immediate commercial sales pathway in UK under CE Mark; no UKCA mark required during the transition.
- Australia performed over 103,556 ART cycles in 2023; Felixâ„¢ is positioned for fresh cycle usage.
- India's IVF market is growing rapidly, offering significant potential for Felixâ„¢ with 300,000 cycles annually.
- The UK market supports both NHS-funded and private clinic networks, suitable for Felixâ„¢ deployment.
- Memphasys executed a supply agreement with Andrology Center in India with activation upon CDSCO approval.
- Felixâ„¢ System combines electrophoresis and size-exclusion membranes for enhanced sperm quality.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Catalina Resources Ltd (CTN) ORDINARY FULLY PAID |
Materials |
$10 |
Breakaway Dam and Evanston Project Updates
|
3 Feb 2026 8:53AM |
$0.092 |
$0.075 |
fallen by
18.48%
|
|
CTN - Price-sensitive ASX Announcement
Full Release
Key Points
- Breakaway Dam confirmed as a copper-rich VMS system.
- Approximately 3,000 meters of RC drilling planned.
- Tenement consolidation to secure contiguous land position.
- Phase 1 drilling at Leghorn Prospect confirms geological model.
- Potential for additional sulphide development at Breakaway Dam.
- Catalina to refine geological model and expand exploration efforts.
- Forward exploration program prioritised following successful 2025 campaign.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Strike Energy Limited (STX) ORDINARY FULLY PAID |
Energy |
$342 |
South Erregulla Power Project
|
3 Feb 2026 8:50AM |
$0.100 |
$0.095 |
fallen by
5%
|
|
| NAOS Small Cap Opportunities Company Limited (NSC) ORDINARY FULLY PAID |
Financials |
$51 |
Q2 FY26 Investor Update and Q&A - Presentation Materials
|
3 Feb 2026 8:50AM |
$0.390 |
$0.385 |
fallen by
1.28%
|
|
| NAOS Ex-50 Opportunities Company Limited (NAC) ORDINARY FULLY PAID |
Financials |
$30 |
Q2 FY26 Investor Update and Q&A - Presentation Materials
|
3 Feb 2026 8:49AM |
$0.685 |
$0.660 |
fallen by
3.65%
|
|
| Jade Gas Holdings Limited (JGH) ORDINARY FULLY PAID |
Energy |
$42 |
Monthly Operations Report - January 2026
|
3 Feb 2026 8:48AM |
$0.026 |
$0.023 |
fallen by
11.54%
|
|
| Aroa Biosurgery Limited (ARX) ORDINARY FULLY PAID |
Health Care |
$223 |
AROA Business Update Presentation
|
3 Feb 2026 8:46AM |
$0.640 |
$0.645 |
risen by
0.78%
|
|
ARX - Price-sensitive ASX Announcement
Full Release
Key Points
- Aroa Biosurgery Limited presented a business update on 3 February 2026.
- The presentation is intended for investor education and not as an offer of securities.
- The Myriad Trauma Study, a large multicenter observational study, is ongoing with 450 patients enrolled.
- The Symphony product has undergone reimbursement changes expected to disrupt the market.
- The presentation includes forward-looking statements and financial guidance.
- Guidance for the financial year includes a revenue target of NZ$92-100 million and EBITDA of NZ$5-8 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.